By DAVID GELLES
The suit calls into focus one of the central issues at play: whether Mr. Ackman improperly built up his nearly 10 percent stake in Allergan as he prepared to make a bid with Valeant for Allergan.
Published: August 1, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1tDaea2
via IFTTT
from WordPress http://ift.tt/1uPA1gK
No comments:
Post a Comment